Vertex Pharmaceuticals Incorporated (VRTX)

NASDAQ: VRTX · Real-Time Price · USD

453.06

+4.77 (1.06%)

At close: May 13, 2026, 4:00 PM EDT

448.46

-4.60 (-1.01%)

Pre-market: May 14, 2026, 6:10 AM EDT

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	114,989	115,149	103,454	104,854	74,220	55,884
Market Cap Growth	-9.81%	11.30%	-1.33%	41.27%	32.81%	-9.02%
Enterprise Value	103,979	110,388	98,882	94,363	64,254	49,246
Last Close Price	453.06	453.36	402.70	406.89	288.78	219.60
PE Ratio	26.87	29.59	-193.61	29.29	22.53	24.37
Forward PE	23.12	22.61	22.66	24.44	18.83	16.42
PEG Ratio	1.84	0.73	1.21	1.92	0.58	1.62
PS Ratio	9.41	9.59	9.39	10.62	8.31	7.38
PB Ratio	5.95	6.17	6.30	5.96	5.33	5.53
P/TBV Ratio	6.02	6.27	6.33	6.03	5.38	5.65
P/FCF Ratio	30.99	36.05	-130.90	31.42	18.91	23.20
P/OCF Ratio	27.12	31.71	-210.01	29.64	17.97	21.14
EV/Sales Ratio	8.51	9.20	8.97	9.56	7.19	6.50
EV/EBITDA Ratio	20.87	25.18	-3847.55	23.51	14.42	16.94
EV/EBIT Ratio	21.68	26.45	-424.57	24.62	14.92	17.70
EV/FCF Ratio	28.02	34.56	-125.12	28.28	16.37	20.45
Debt / Equity Ratio	0.10	0.10	0.09	0.04	0.06	0.09
Debt / EBITDA Ratio	0.41	0.42	-60.09	0.18	0.18	0.31
Debt / FCF Ratio	0.54	0.58	-1.95	0.22	0.21	0.37
Net Debt / Equity Ratio	-0.27	-0.25	-0.28	-0.60	-0.72	-0.66
Net Debt / EBITDA Ratio	-1.07	-1.09	177.88	-2.61	-2.24	-2.28
Net Debt / FCF Ratio	-1.42	-1.49	5.79	-3.14	-2.54	-2.76
Asset Turnover	0.47	0.50	0.49	0.48	0.57	0.60
Inventory Turnover	0.97	1.14	1.57	2.10	2.66	2.85
Quick Ratio	2.38	2.24	2.17	3.60	4.46	4.04
Current Ratio	3.02	2.90	2.69	3.99	4.83	4.46
Return on Equity (ROE)	22.82%	22.54%	-3.15%	22.99%	27.67%	24.93%
Return on Assets (ROA)	15.08%	14.75%	2.22%	15.49%	21.41%	18.95%
Return on Invested Capital (ROIC)	25.07%	24.66%	4.62%	47.15%	75.33%	63.08%
Return on Capital Employed (ROCE)	21.09%	20.48%	-1.22%	22.16%	32.27%	26.29%
Earnings Yield	3.77%	3.38%	-0.52%	3.41%	4.44%	4.10%
FCF Yield	3.23%	2.77%	-0.76%	3.18%	5.29%	4.31%
Buyback Yield / Dilution	0.15%	-0.04%	1.00%	-0.54%	0.31%	1.33%
Total Shareholder Return	0.15%	-0.04%	1.00%	-0.54%	0.31%	1.33%

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q